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Abstract
Loxoscelism is the designation given to clinical symptoms evoked by Loxosceles spider’s bites. Clinical manifestations
include skin necrosis with gravitational spreading and systemic disturbs. The venom contains several enzymatic toxins.
Herein, we describe the cloning, expression, refolding and biological evaluation of a novel brown spider protein
characterized as a hyaluronidase. Employing a venom gland cDNA library, we cloned a hyaluronidase (1200 bp cDNA) that
encodes for a signal peptide and a mature protein. Amino acid alignment revealed a structural relationship with members
of hyaluronidase family, such as scorpion and snake species. Recombinant hyaluronidase was expressed as N-terminal His-
tag fusion protein (,45 kDa) in inclusion bodies and activity was achieved using refolding. Immunoblot analysis showed
that antibodies that recognize the recombinant protein cross-reacted with hyaluronidase from whole venom as well as an
anti-venom serum reacted with recombinant protein. Recombinant hyaluronidase was able to degrade purified hyaluronic
acid (HA) and chondroitin sulfate (CS), while dermatan sulfate (DS) and heparan sulfate (HS) were not affected. Zymograph
experiments resulted in ,45 kDa lytic zones in hyaluronic acid (HA) and chondroitin sulfate (CS) substrates. Through in vivo
experiments of dermonecrosis using rabbit skin, the recombinant hyaluronidase was shown to increase the dermonecrotic
effect produced by recombinant dermonecrotic toxin from L. intermedia venom (LiRecDT1). These data support the
hypothesis that hyaluronidase is a ‘‘spreading factor’’. Recombinant hyaluronidase provides a useful tool for
biotechnological ends. We propose the name Dietrich’s Hyaluronidase for this enzyme, in honor of Professor Carl Peter
von Dietrich, who dedicated his life to studying proteoglycans and glycosaminoglycans.
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Introduction
Bites involving brown spiders are characterized by skin
injuries at the venom inoculation site, including swelling,
erythema, hemorrhage, dermonecrosis, and the hallmark of
loxoscelism: gravitational spreading of cutaneous lesions [1,2].
Systemic involvement has also been reported including fever,
malaise, weakness, nausea, vomiting and in severe cases,
intravascular coagulation, hemolysis and acute renal distur-
bance [1,2,3,4,5].
The gravitational spread of skin lesions is a distinct character-
istic of loxoscelism, described after experimental venom exposure
in the skin of rabbits and in real cases. It appears hours or days
after venom inoculation. Macroscopically, the development of
lesions disperses in a gravitational direction with erythema,
swelling, dark blue-violet color, and an eschar. Histologically,
the lesion is reported as a collection of inflammatory cells in and
around the blood vessels and diffusely distributed in the dermis. It
is also possible to observe degeneration of blood vessel walls,
disorganization of collagen fibers with edema, hemorrhage into
the dermis, necrosis of cells, and destruction of tissue structures.
Pathologically, the wound is described as aseptic coagulative
necrosis [1,2,6,7,8].
The molecular mechanism by which brown spider venom
induces gravitational spreading of skin lesions and systemic
involvement is not fully understood. A fundamental requirement
for venom to induce local spreading of lesions and systemic
involvement is the presence of venom components that are able to
degrade tissue barriers. The delivery of venom toxins to
neighboring bite sites and into systemic circulation is assisted by
molecules that degrade extracellular matrix constituents such as
proteases and hyaluronidases [9,10,11,12].
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The venom is a mixture of proteins enriched in molecules with
low molecular mass in the range of 5–40 kDa. Toxins including
hyaluronidase, proteases, low molecular mass insecticidal peptides,
Translationally Controlled Tumor Protein (TCTP) and phospho-
lipases-D have been identified [1,2,13,14,15,16,17].
The existence of hyaluronidases in Loxosceles venoms comes from
a previous report by Wright et al. (1973) [18], which reported
hyaluronidase activity in the venom of L. reclusa. Additionally,
hyaluronidase activity was described in the venom of L. rufescens
[19] and several other Loxosceles venoms, including L. deserta, L.
gaucho, L. intermedia, and L. laeta [11], suggesting biological
conservation and significance of these enzymes. Da Silveira and
colleagues (2007) [20] identified the hyaluronidases in Loxosceles
intermedia venom as endo-b-N-acetyl-D-hexosaminidases that
degrade hyaluronic acid and chondroitin sulfate. The idea that
brown spider venom hyaluronidases play a role in the gravitational
spreading of dermonecrosis and/or systemic diffusion of venom
toxins, and then act as ‘‘spreading factors’’ comes from its
degradative activity on hyaluronic acid and other glycosamino-
glycans that mediate tissue integrity and stability. By degrading
glycosaminoglycans, the hyaluronidase reduces the viscosity of
hyaluronic acid and renders the extracellular matrix less rigid.
This change makes the matrix more permeable to other toxins and
facilitates the spread of other venom constituents and inflamma-
tory cell mediators [21,22].
Although hyaluronidase activity has been described in several
venoms including that of snakes [10,23], scorpions [24] spiders
[22], bees [25], caterpillars [26], wasps [27], cone snails [28] and
fish [29], the biochemical and biological characterization of these
enzymes is restricted to a few examples [10,21,30]. In the case of
the brown spider, the major technical problem is the minute
volume of venom obtained per animal. The total volume
harvested after an electric shock on the cephalothorax of the
spider is limited to one or two microliters, and contains a few tens
of micrograms of protein [31]. Purification of this native
glycosidase to homogeneity for additional biochemical determi-
nation has not yet described for brown spider venom, and would
be a very difficult task.
In recent years, using molecular biology techniques, scientists
have obtained sufficient amounts of various recombinant toxins
from brown spider venom to bring deeper insight into the
molecular action of these toxins. Various venom phospholipase D
isoforms and an Astacin-like metalloprotease have been reported
for various species of spider venom [20,32,33,34,35,36].
Here, by using a cDNA library of L. intermedia venom glands
[15], we described the cloning, heterologous expression and
functional evaluation of a novel hyaluronidase. The results bring
insight into loxoscelism, opening up possibilities for biotechnolog-
ical applications for this recombinant enzyme as a research tool.
This recombinant hyaluronidase would also be useful in future
structural and functional studies of this class of enzymes.
Methods
Reagents
Salts and organic acids were purchased from Merck (Darmstadt,
Germany). Agar, b mercaptoethanol, molecular mass markers and
purified hyaluronic acid were purchased from Sigma (St. Louis,
USA). Ethidium bromide, a Wizard Plus SV miniprep kit and
pGEM-T vector were acquired from Promega (Madison, USA).
Agarose, IPTG and Trizol were purchased from Invitrogen
(Carlsbad, USA). We acquired DNA molecular mass standards, X-
Gal, Taq DNA polymerase, Pfu DNA polymerase, T4 DNA
ligase, restriction enzymes, dNTPs and CIAP from Fermentas
(Burlington, Canada). For bacterial culture, we used tryptone,
yeast extract and agar purchased from HiMedia (Mumbai, India).
The antibiotics were purchased from USB (Cleveland, USA). The
bacterial strains used in this study and the ImPromII Reverse
Transcription System kit were acquired from Invitrogen. We
purchased the pET-14b expression plasmid from Novagen
(Novagen, Madison, USA). The glycosaminoglycan standards
used were heparan sulfate from bovine pancreas [37], chondroitin
sulfate from bovine cartilage and dermatan sulfate from pig skin
(Seikagaku, Kogyo Co., Tokyo, Japan).
cDNA library construction and screening
The venom gland cDNA library construction was performed as
described by Gremski et al. (2010) [15]. Briefly, processed
sequences were compared to GenBank sequences using the Basic
Local Alignment Search Tools blastx, blastn (E values,1e-05) and tblastx
(E values,1e-10) algorithms. Afterwards, ESTs were manually
inspected for functional classification. One toxin-coding messenger
similar to a hyaluronidase from Rattus novergicus (gb|EDL77243.1)
was found in this cDNA library and was used as a base sequence.
Amplification of the cDNA 59 end
To obtain the complete 59 end of hyaluronidase cDNA, a
59RACE (Rapid Amplification of 59cDNA Ends) protocol was
performed following Sambrook and Russel (2001) [38] with minor
modifications. Briefly, 1 mg total RNA from L. intermedia venom
glands was used as a template. The first-strand cDNA was
synthesized using the gene-specific reverse primer R1 (59-
GTTGCAGGGTAGACAACATCCACG-39) and the Improm-
II Reverse Transcriptase (Promega), according to the manufac-
turer’s instructions. The cDNA was recovered by ethanol
precipitation in the presence of ammonium acetate. The cDNA
was poly(A) tailed with terminal deoxynucleotidyl transferase
(Fermentas), as recommended by the supplier. The modified
cDNA was amplified using PCR with a (dT)17 adaptor primer
(59-CGGTACCATGGATCCTCGAGTTTTTTTTTTTTTTT-
Author Summary
Accidents involving brown spiders (Loxosceles genus) are
reported throughout the world. South and Southeast of
Brazil are endemic areas for this spider. Loxosceles bites
commonly trigger local signs as swelling, erythema,
hemorrhage and the hallmark symptom: a dermonecrotic
lesion with gravitational spreading. Systemic effects are
less common; however, are implicated in more severe
cases. Hyaluronidases are referred in several venoms as
‘‘spreading factors’’ due to their enzymatic activity upon
extracellular components. This activity facilitates the
permeation of other toxins through the victim’s body. In
fact, a previous study identified the activity of L. intermedia
venom upon glycosaminoglycans which are abundant
components in the extracellular matrix of many tissues.
Disclosing a little more about the role of hyaluronidases
within this venom, we investigated the activities of a
recombinant hyaluronidase from L. intermedia venom.
Dietrich’s hyaluronidase, as it was designated, was
produced as a recombinant protein. By performing a
rabbit skin dermonecrosis assay using Dietrich’s Hyaluron-
idase and a dermonecrotic toxin, we showed that
Dietrich’s Hyaluronidase increased the dermonecrotic area
induced by the dermonecrotic toxin. Our results confirm
that hyaluronidases are a ‘‘spreading factor’’ of L. inter-
media venom.
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TTV-39) and the nested gene-specific reverse primer R2 (59-
CTCCATGCTTCCCAGTCGATGATGC-39) using a Pfu DNA
polymerase (Fermentas). Finally, the PCR product was purified
from the gel using Illustra GFX PCR DNA and a Gel Band
Purification kit (GE) following the manufacturer’s instructions and
sequenced on both strands using MegaBace DNA Analysis
Systems (Amersham Bioscience).
Amplification of the cDNA 39end
To achieve the complete sequence, a 39RACE (Rapid
Amplification of 39cDNA End) protocol was modified from
Sambrook and Russel [38]. Briefly, 1 mg total RNA from L.
intermedia venom glands was used to synthesize the first-strand
cDNA using the gene-specific forward primer F1 (59-CGAAT-
CAATCAACGGTGGCATCCCTC-39) and the Improm-II Re-
verse Transcriptase (Promega). The cDNA was recovered as
previously described. The cDNA was amplified with F2 (59 -
CCGCATTGGTTTTAGCCGCATTC-39), (dT)17 adaptor prim-
er (59 -CGGTACCATGGATCCTCGAGTTTTTTTTTTTT-
TTTTTV-39) and Pfu DNA polymerase (Fermentas). Purification
from the gel with a Gel Band Purification kit (GE) was performed
according to manufacturer’s instructions, and the amplicon was
sequenced on both strands.
Recombinant protein expression
The cDNAs encoding the putative mature hyaluronidase, which
we named Dietrich’s Hyaluronidase, were amplified with PCR
using primers designed to contain Nde I restriction sites at the 59
ends (59-GGAATTCCATATGGACGTCTTCTGGAACG-39)
and BamH I sites (59-CGGGATCCCTCACTTTGTTTT-
CTGCTC-39). The PCR product was digested with Nde I and
BamH I restriction enzymes. Subcloning was performed with a
pET-14b plasmid (Novagen) digested with the same enzymes. The
recombinant construct for mature protein was expressed as a
fusion protein with a 66 His-Tag at the N-terminus. The
expression construct was inserted into E. coli BL21(DE3)pLysS
cells and plated on LB-agar plates containing 100 mg/mL
ampicillin and 34 mg/mL chloramphenicol. Single colonies of
the construct were inoculated into LB broth (100 mg/mL
ampicillin and 34 mg/mL chloramphenicol) and grown overnight
at 37uC. These cultures were diluted 1:100 into 1 L fresh LB
broth/ampicillin/chloramphenicol and incubated at 37uC until
the OD550 nm= 0.4–0.6. Recombinant protein expression was
induced by the addition of 0.1 mM IPTG (isopropyl b-D-
thiogalactoside) and cells were incubated for 3.5 h at 30uC in a
shaker. Cells were harvested by centrifugation (4,0006g, 7 min-
utes, 4uC), suspended in 20 mL of extraction buffer (50 mM
sodium phosphate pH 8.0, 500 mM NaCl, 10 mM imidazole,
1 mg/mL lysozyme) and frozen at 220uC overnight.
In vitro refolding of Dietrich’s Hyaluronidase
Cells were thawed and disrupted with 8 cycles of sonication at
medium intensity for 20 seconds using a 500-W ultrasonic cell
disruptor. Lysed materials were centrifuged (20,0006g, 30 min-
utes, 4uC), and the pellet was washed with a denaturing buffer
(100 mM Tris-HCl pH 10.0, 2 M urea, 1% Triton X-100) and
sonication at low intensity. After centrifugation at 6,0006g for
10 minutes the resulting pellet was solubilized in 100 mM Tris-
HCl pH 10.0 with 8 M urea and 100 mM DTT. The solution
containing denatured and reduced recombinant protein was
adjusted to a concentration of ,5 mg/mL and was added
dropwise (1:10 ratio) to a refolding buffer (100 mM Tris-HCl
pH 10.0, 3 mM reduced glutathione, 0.3 mM oxidized glutathi-
one, 0.4 M L-arginine, 0.2 mg bovine serum albumin) by stirring
over 16 h at 4uC. The protocol used was based on the works of
Burgess et al. and Hofinger and co-workers [39,40]. Dialysis was
against phosphate buffered saline, and recombinant hyaluronidase
was concentrated using filter devices (MWCO 30,000 Millipore,
Schwalbach, Germany).
SDS-PAGE and immunoblotting
Polyclonal antibodies against L. intermedia whole venom and
against recombinant hyaluronidase were produced in rabbits as
described by Harlow and Lane (1988) [41], with minor
modifications [42]. Protein concentration was determined using
the Coomassie Blue method [43] or ultraviolet measurement
(280 nm). For protein analysis, 12.5% SDS-PAGE was performed
under reducing conditions and gels were stained with Coomassie
Blue. For immunoblotting, proteins were transferred onto a
nitrocellulose membrane following Towbin et al. (1979) [44] and
immunodetected using hyperimmune antisera, which reacts with
hyaluronidase or venom.
Specificity of Dietrich’s Hyaluronidase activity upon
glycosaminoglycan substrates
Agarose gel electrophoresis was developed in 50 mM Tris–
acetate buffer at pH 8.0 to evaluate hyaluronic acid degradation.
Electrophoresis was performed in 50 mM 1,3-diaminopropane
acetate buffer, pH 9.0 (Aldrich, Milwaukee, USA) to evaluate the
cleavage activity of glycosidase on chondroitin sulfate, dermatan
sulfate and heparan sulfate. After electrophoresis, compounds
were precipitated in the gel using 0.1% cetavlon (cetylammonium
bromide) for 2 h at room temperature. The gels were dried and
stained with Toluidine Blue. The glycosaminoglycan standards
used were as previously described [20,45]
Ethics statement
The Ethics Animal Experiment Commitee of the Setor de
Cieˆncias Biolo´gicas of the Federal University of Parana,
established by the decree 787/03-BL from May 9th 2003, and
upon the internal regiment, certifies that the procedures using
animal in this work are in agreement with the Ethical Principals
established by Experimental Animal Brazilian Council (COBEA),
and with the requirement of the ‘‘Guide for the Care and Use of
Experimental Animals (Canadian Council on Animal Care)’’.
Processes numbers: 23075.052088/2008-32 Approved: April 7,
2009 and 23075.087106/2011-01 Approved: August 9, 2011.
Animals
Adult rabbits (,3 kg) from the Central Animal House of the
Catholic University of Parana were used for in vivo experiments
with whole venom and recombinant enzymes (the product of
antibodies and dermonecrosis studies). All procedures involving
animals were carried out in accordance with Brazilian Federal
Law, following the Ethical Subcommittee on Research Animal
Care from the Federal University of Parana.
Dermonecrosis and gravitational spreading
To evaluate the potential gravitational spreading effect of brown
spider hyaluronidase, 10 mg of a recombinant dermonecrotic toxin
(LiRecDT1) diluted in PBS was injected intradermally into a
shaved area of rabbit skin with or without recombinant
hyaluronidase (10 mg). For the same purpose 10 mg of Dietrich’s
Hyaluronidase alone (diluted in PBS with 0.2 mg/mL BSA) was
also injected. We used two negative controls: one was PBS with
0.2 mg/mL BSA, to assure that BSA used to refold recombinant
hyaluronidase did not induce changes. The other was a
Hyaluronidase from Loxosceles Brown Spider Venom
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recombinant protein with similar molecular mass obtained under
the same conditions as hyaluronidase, but without hyaluronidase
activity. The last assay guarantees that potential bacterial
contaminants did not influence the results. Ten micrograms of
venom and dermonecrotic toxin were used as positive controls.
Rabbits were used in dermonecrosis experiments because this
model reproduces skin lesions very close to those observed in
accidents with humans [46]. Experiments were repeated with 4
animals and the development of experimentally induced dermo-
necrosis was observed 3 h, 6 h and 24 h after the injection.
Histological methods for light microscopy
Rabbit skin pieces from animals that intradermally received
recombinant proteins were collected following anesthetization with
ketamine (Agribands, Campinas, Brazil) and acepromazine
(Univet, Sa˜o Paulo, Brazil). Collected tissue samples were fixed
in ‘‘ALFAC’’ (ethanol 85%, formaldehyde 10% and glacial acetic
acid 5%) for 16 h at room temperature. After fixation, samples
were dehydrated in a graded series of ethanol before paraffin
embedding (for 2 h at 58uC). Thin sections of 4 mm thickness were
processed for histological procedures [42]. Tissue sections were
stained with Masson’s trichrome (TM) as described [47].
Bioinformatics tools
To compare new sequences generated against the GenBank
database, we used the BLAST site (http://blast.ncbi.nlm.nih.gov/
Blast.cgi). The parameters for blastn were refined by selecting the
‘‘others’’ search set with E values ,1e-05. For blastx, we chose
standard genetic code 1 and non-redundant protein sequences
with E values ,1e-05 parameter. Deduced amino acid sequence
was found using the Open Reading Frame Finder site (http://
www.ncbi.nlm.nih.gov/projects/gorf/) and an analysis of protein
parameters and glycosylation modifications was conducted using
the ExPASy Bioinformatics Research Portal (http://web.expasy.
org/protparam/). Disulfide bond prediction was made using the
DiANNA 1.1 web server http://clavius.bc.edu/,clotelab/
DiANNA/. CLUSTAL W (http://www.ebi.ac.uk/Tools/msa/
clustalw2/) was used for alignment and cladogram production.
Finally, to search any possible signature recognition within
Dietrich’s Hyaluronidase sequence, we used the InterProScan site
(http://www.ebi.ac.uk/Tools/pfa/iprscan/).
Genbank accession number
The Dietrich’s Hyaluronidase cDNA sequence has been
submitted to the Genbank database under accession number
JX402631.
Results
Cloning of a hyaluronidase from the L. intermedia venom
gland
By screening clones of a cDNA library of the L. intermedia venom
gland, a cDNA encoding for a hyaluronidase was obtained
through a blastx search [15]. The putative protein product from
this cDNA was designated Dietrich’s Hyaluronidase (in honor and
memoriam of Professor Carl Peter von Dietrich, born in 1936,
deceased in 2005). The complete cDNA sequence of Dietrich’s
Hyaluronidase consist of 1200 bp with a single open reading frame
(ORF) coding for 400 amino acids and a putative N terminal
endoplasmic reticulum import signal of 19 residues. At least two
types of post translational modification were observed: 4 putative
N-glycosylation sites and 3 possible disulfide bonds (Fig. 1). The
predicted molecular mass for mature Dietrich’s Hyaluronidase
protein was approximately 44.8 kDa, and its pI was 8.75.
Multiple alignment analysis of the cDNA-deduced amino
acid sequence and the cladogram relationship of
Dietrich’s Hyaluronidase to other hyaluronidase family
members
To explore the structural and evolutionary relationships among
the newly identified glycosidase and other members of the
hyaluronidase family, a BLAST GenBank database search
through alignment of cDNA-deduced amino acid sequences
revealed that Dietrich’s Hyaluronidase has structural similarity
to other hyaluronidase family members (Fig. 2A). The overall
identity of hyaluronidase from L. intermedia venom is approximately
46% compared with the scorpion venom hyaluronidase of
Mesobuthus martensii (gb|ACY69673.1). Dietrich’s Hyaluronidase
is also similar to snake venom hyaluronidases, sharing 33%
sequence identity with Echis pyramidium (gb|ABI33941.1) and
Cerastes cerastes (gb|ABI33939.1). Interestingly, the enzyme from
an arthropod venom showed approximately 30% amino acid
identity with hyaluronidases from mammal species such as Bos
taurus (gb|AAP55713.1) and Rattus novergicus (gb|EDL77243.1)
(Fig. 2B). An InterProScan search matches Dietrich’s Hyaluron-
idase with more than 500 proteins belonging to the glycoside
hydrolase 56 family. A typical signature domain for hyaluronidases
has not yet been demonstrated, and there are few studies about of
the residues involved in catalysis [30,48]. However, the hyaluron-
idase from L. intermedia venom has 3 conserved amino acids
(indicated in Fig. 2A at arrows: D118, E120, E259) that appear to
be important for the catalytic activity of some hyaluronidases [30].
Expression, purification and refolding of Dietrich’s
Hyaluronidase
Recombinant hyaluronidase from L. intermedia venom was
expressed in pET 14b in E. coli BL21(DE3)pLysS cells. The
expression of recombinant protein was optimized when induced
for 3.5–5 h with 0.1 mM of IPTG. The recombinant protein was
detected only in the insoluble fraction of cell lysates and was
purified under denaturing conditions by washing inclusion bodies
until there were no bacterial contaminants visible in SDS-PAGE
gels stained with Coomassie blue. The SDS-PAGE mobility of
recombinant protein reduced by b-mercaptoethanol treatment
was ,45 kDa, consistent with the calculated molecular mass
(Fig. 3). After testing several refolding protocols in vitro (data not
shown), the protocol described in the methods section, was
effective in solubilizing recombinant hyaluronidase from inclusion
bodies, as shown in lane 4 (Fig. 3).
Immuno cross-reactivity among native and recombinant
hyaluronidases
Immunoblot analysis using antibodies against recombinant
hyaluronidase (Dietrich’s Hyaluronidase) and antibodies against
whole venom toxins established the epitope relationship of native
hyaluronidase with recombinant enzyme (Fig. 4). Antibodies
against Dietrich’s Hyaluronidase recognize hyaluronidase in the
whole venom, as well as anti-whole venom serum reacted with
recombinant glycosidase.
Hyaluronidase activity on HA and CS
To evaluate the activity of Dietrich’s Hyaluronidase after
refolding, purified HA was incubated at a ratio of 1:1 with
recombinant hyaluronidase for 3 h, 6 h and 16 h at 37uC. The
enzymatic activity was analyzed through agarose gel electropho-
resis stained with toluidine blue. HA was completely degraded
within 3 h (Fig. 5A, lane 3) showing that the in vitro refolding
method was effective in adjusting hyaluronidase in an active
Hyaluronidase from Loxosceles Brown Spider Venom
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conformation. Through analysis with CS, DS and HS at a
substrate-to-enzyme ratio of 1:1, we noted that recombinant
hyaluronidase degraded CS (Fig. 5B, lane 3) and did not degrade
DS and HS (data not shown), similar to the native hyaluronidases
from venom.
To verify the stability of refolding in vitro achieved with
recombinant hyaluronidase, we performed a zymogram assay
using gels containing copolymerized purified HA and CS as
substrates. Hydrolytic activity was found as a specific band
between the 29–45 kDa regions in both substrates and strength-
ened the results described above (Fig. 5C).
Gravitational spreading
We sought to develop dermonecrosis experiments using rabbit
skin to determine the in vivo involvement of brown spider venom
hyaluronidase in envenomation. Moreover, we aimed to observe
the relationship of hyaluronidases in the skin deleterious activities
of whole venom. Injections of L. intermedia crude venom,
recombinant dermonecrotic toxin [33] (positive controls), and
dermonecrotic toxin plus Dietrich’s Hyaluronidase all induced
macroscopic erythema, ecchymosis and dermonecrosis in rabbit
skin, which was followed by 3, 6 and 24 h of observation (Fig. 6A
and Fig. 6B). On the other hand, the injection of recombinant
hyaluronidase alone, PBS/BSA and a recombinant protein not
related to hyaluronic acid hydrolysis (negative controls) did not
show macroscopic erythema, ecchymosis or dermonecrosis (Fig. 6A
and Fig.6B). The length of dermonecrosis lesions in the rabbit skin
of Dietrich’s Hyaluronidase concomitantly injected with dermo-
necrotic toxin was substantially larger than for dermonecrotic
toxin alone after 24 h (Fig. 6B). The macroscopic gravitational
spreading and edema induced by the two recombinant enzymes
injected together were very similar to whole venom (Fig. 6C).
Histopathological findings of dermonecrosis
Light microscopic analysis of rabbit skin biopsies 24 h after of
the experimentally induced dermonecrosis experiments performed
above suggested that recombinant hyaluronidase was able to
disorganize the extracellular matrix from rabbit skin dermis
(Fig. 7B-4). Dermonecrotic toxin alone triggered typical inflam-
matory cell accumulation (Fig. 7B-2 and 7B-5) and edema signals
(Fig. 7A, 7B-5), as well as collagen fiber disorganization (Fig. 7B-5)
and presence of fibrin in connective tissue (Fig. 7B-5). Neverthe-
less, we noticed that these inflammatory events, developed by
dermonecrotic toxin, were intensified when combined with
Dietrich’s Hyaluronidase (Fig. 7A; 7B-3 and 7B-6), supporting
an extensive edema and spreading of lesion. By comparison, using
a panoramic image under the same conditions, deleterious effects
induced by dermonecrotic toxin alone were lower than those
evoked by mixture of this toxin and Dietrich’s Hyaluronidase
(Fig. 7A). These microscopic findings corroborate the information
obtained by macroscopic analysis of rabbit skin lesions.
Discussion
Hyaluronidases are present in various tissues and are involved in
important biological events, including embryonic development,
inflammation, fertilization, tumor cell metastasis, bacterial path-
ogenesis and aging [10,14]. These enzymes were described many
Figure 1. Molecular cloning of Dietrich’s Hyaluronidase, a novel protein from L. intermedia venom gland. Nucleotide- and amino-acid-
deduced sequences. Predicted amino acid sequence, with 400 amino acid residues and signal peptide underlined. Rectangular boxes are the
predicted N-glycosylation sites (ExPASy tools parameters), and asterisks indicate cysteine residues that may constitute disulfide bonds (DiANNA web
server). Arrows indicate primers with restriction sites (bold nucleotides) used for subcloning into pET 14b.
doi:10.1371/journal.pntd.0002206.g001
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years ago in the venom of different Loxosceles species, featuring a
conservative event and suggesting biological significance in the life
cycle of these spiders [1,2,11]. A more refined understanding of
brown spider venom hyaluronidase is hampered by native
molecules present in low amounts in the venom and by extremely
minute volume of venom obtained from spiders [2,15,49].
Here, we described the cloning, heterologous expression,
purification, refolding and characterization of a novel hyaluron-
idase from a cDNA library of the L. intermedia venom gland. These
results corroborate previous biochemical data that have described
these enzymes in brown spider venom from different species
[11,20]. The recombinant protein identified herein is designated
Dietrich’s Hyaluronidase (GenBank Accession no. JX402631).
The primary sequence of Dietrich’s Hyaluronidase includes a
hydrophobic signal sequence of 19 residues and a mature protein.
The hydrophobic signal sequence probably directs its expression to
the endoplasmic reticulum in venom gland epithelial cells. The
molecular mass and isoelectric point calculated from the deduced
amino acid sequence of mature protein were 44.8 kDa and pI
8.75, respectively. The theoretical molecular mass is within the
expected range, considering the size of brown spider venom native
hyaluronidases [11,20], and the isoelectric point was similar to the
calculated pI of hyaluronidases from other venoms. A protein
sequence analysis of brown spider venom hyaluronidase compared
to hyaluronidases from different sources showed that this venom
enzyme has conserved amino acids (D118, E120, E259) that seem
to be important for catalytic hydrolysis [30,48]. Dietrich’s
Hyaluronidase was assigned to the Glycosidase 56 family; which
compose a wide group of O-glycosyl-hydrolases [50]. The highest
similarity to Dietrich’s hyaluronidase was found in the sequences
of scorpion hyaluronidase from Mesobuthus martensii venom (46%
amino acid identity) and the snake venom of Echis pyramidium and
Cerastes cerastes (33%). As might be expected, the hyaluronidase
from L. intermedia venom was particularly similar to hyaluronidases
from other venoms. However, we highlight Dietrich’s Hyaluron-
idase’s significant identity with mammalian species such as Bos
taurus and Rattus novergicus. This fact, coupled with its activity at
physiological pH, would be interesting for pharmaceutical use.
Dietrich’s Hyaluronidase was heterogeneously expressed as a
mature protein with an N-fusion His-tag using the E. coli
BL21(DE3)pLysS strain. Isolation of the recombinant glycosidase
was performed by washing inclusion bodies with denaturing
buffer. The purification of recombinant proteins from inclusion
bodies might be advantageous, because it is protease-resistant and
is close to functional native structure [51,52,53].
Characterization of the antigenic cross-reactivity of recombi-
nant hyaluronidase and L. intermedia venom showed that the venom
contains proteins that have antigenic identity (sequence epitopes)
with recombinant hyaluronidase because antisera raised against
recombinant enzyme was able to react with native venom. Two
protein bands of the whole venom were recognized by hyaluron-
idase antisera, corroborating with previous results that showed two
Figure 2. Multiple alignment analysis of Dietrich’s Hyaluronidase sequence and several others hyaluronidases. (A) Deduced amino
acid sequences compared and their GenBank accession numbers: Cerastes cerastes (ABI33939.1); Echis pyramidum leakey (ABI33941.1); PH-20 Bos
taurus (AAP55713.1); Hyaluronidase-2 precursor Salmo salar (ACI33947.1); lysosomal hyaluronidase Xenopus laevis (AAL55823.1); hyaluronogluco-
saminidase 1 Mus musculus (AAC15949.1); hyaluronidase 1 Sus scrofa (ACH56985.1); venom hyaluronidase Mesobuthus martensii (ACY69673.1);
hyaluronoglucosaminidase 1 Rattus norvegicus (EDL77243.1) and Loxosceles intermedia (JX40263.1). Black shaded regions show amino acid identity
and gray shaded regions, conservative substitutions. Arrows indicate conserved amino acids that appear to be important for catalytic hydrolysis. (B)
Deduced cladogram of the cloned hyaluronidase and family members based on sequence alignment and percent identity generated by CLUSTAL W.
doi:10.1371/journal.pntd.0002206.g002
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lytic zones in zymography experiments using whole venom in a gel
co-polimerized with hyaluronic acid. Those bands probably
correspond to two isoforms of hyaluronidase present in L. intermedia
whole venom [11,20]. Additionally, anti-venom cross-reacted with
the recombinant hyaluronidase, suggesting that the recombinant
glycosidase retains linear antigenic determinants from native
hyaluronidases. In this way, the antisera to Dietrich’s Hyaluron-
idase or purified antibodies from it could be a possible biological
tool in loxoscelism therapy or for research purposes.
The functionality of refolded recombinant hyaluronidase was
demonstrated through its activity upon purified hyaluronic acid
and chondroitin sulfate. Dietrich’s Hyaluronidase was able to
directly degrade hyaluronan and chondroitin sulfate. These results
are in agreement with previous data reported for native
hyaluronidases from whole venom, which degrade both glycos-
aminoglycans [20]. The hydrolytic activity found at 29–45 kDa in
zymogram assays copolymerized with hyaluronic acid and
chondroitin sulfate corroborates with the degrading activity of
glycosaminoglycans viewed in agarose gels, suggesting certain
stability in the active folding of Dietrich’s Hyaluronidase acquired
after refolding in vitro. Again, results show that recombinant
hyaluronidase can also be considered a chondroitinase, as
previously reported for native hyaluronidases [20].
Regarding in vitro refolding it is worth mentioning that buffers
with different pHs, redox agents and additives were tested [39,54]
until the solubility and activity of Dietrich’s Hyaluronidase was
maximized (data not shown). When bovine albumin was removed
from the buffer, the hyaluronidase activity was null. This result is
consistent with the literature that describes how BSA may compete
with hyaluronidases to form inactive electrostatic complexes with
hyaluronic acid. This competition induces free hyaluronidase
resulting in a large increase in the hydrolysis rate [55]. Several
research groups have reported that serum proteins are able to
enhance hyaluronidase activity and are sometimes required to
detect the presence of hyaluronidases [55,56,57].
But what is the role of brown spider venom hyaluronidase on
bite pathology? The involvement of hyaluronidase on the activity
of brown spider venom is supported by the conservative
phenomenon of this enzyme, which indeed is found in different
species of Loxosceles venoms [11]. Hyaluronidases have been
described for several venoms [26,55,58] and act as ‘‘spreading
factors’’ by degrading hyaluronic acid and chondroitin sulfate. In
this way, venom hyaluronidases may render surrounding regions
at the bite site more permeable. Furthermore, these enzymes may
facilitate the diffusion of other venoms constituents through the
bodies of victims [10,58]. A hyaluronidase isolated from funnel
web spider venom was able to enhance the potency of a myotoxin
and a hemorrhagic toxin. This work is in accordance with the
hypothesis that hyaluronidase mediates enhanced toxicity of whole
venom during envenomation [22].
A typical symptom of loxoscelism is the gravitational spreading
of skin lesions that appear a few hours after bites or experimental
envenomation of animal models [1,2]. The mechanism by which
Loxosceles venom causes gravitational spreading of dermonecrosis is
not fully understood. Experimental inoculation of purified
recombinant dermonecrotic toxins (phospholipases-D, non-pro-
teolytic or hyaluronidase activities), evokes gravitational spreading
of skin lesion on rabbits [34]. Macroscopically, Dietrich’s
Hyaluronidase increases the erythema, ecchymosis and dermone-
crotic lesion area induced by recombinant phospholipase-D along
exposure times observed. Histopathological findings for the
dermonecrotic toxin exposed tissue samples revealed, as expected,
the presence of a neutrophilic infiltrate, collagen fiber disorgani-
zation and signs of edema [36,46]. However, when we analyzed
tissue samples treated with phospholipase-D toxin plus Dietrich’s
Hyaluronidase, we observed that these inflammatory evidences
were much more intense, as if recombinant hyaluronidase was
allowed a free diffusion of phospholipase D by rendering the
connective tissue more permeable. For the first time in the
literature, experimental results strongly indicate that the hyal-
uronidase from Loxosceles venom is in fact a ‘‘spreading factor’’ for
this venom.
For brown spider venom hyaluronidase, based on the spreading
property, we extrapolated that this molecule would be primarily
responsible for spreading other venom toxins from the bite site into
Figure 3. Heterologous expression, purification and refolding
of Dietrich’s Hyaluronidase. Expression of recombinant protein in E.
coli BL21(DE3)pLysS was analyzed via 12.5% SDS-PAGE under reducing
conditions and Coomassie blue staining. Lanes 1 and 2 depict E. coli
before (0 h) and after induction (4 h) with 0.1 mM IPTG at 30uC,
respectively. Lane 3 shows inclusion bodies after washing in denaturing
conditions. Lane 4 shows recombinant hyaluronidase refolded in vitro at
,45 kDa (arrow). Band at 67 kDa is BSA used during refolding
(arrowhead). Molecular mass marker positions are shown in the left of
figure.
doi:10.1371/journal.pntd.0002206.g003
Figure 4. Immunological cross-reactivity of whole venom and
Dietrich’s Hyaluronidase. Purified recombinant glycosidase (2.0 mg;
lanes 1, 2, 5 and 6) or whole venom (40 mg; lanes 3 and 4) were
separated by 12.5% SDS-PAGE under reducing conditions, transferred
onto nitrocellulose membranes and exposed to antibodies against
Dietrich’s Hyaluronidase (lanes 2 and 4) or whole venom toxins (lane 6).
Lanes 1, 3 and 5 indicate reactions in the presence of pre-immune sera
(control for antibody specificity). Molecular mass marker positions are
shown in the left of figure.
doi:10.1371/journal.pntd.0002206.g004
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Figure 5. Detection of degradative activities of Dietrich’s Hyaluronidase upon hyaluronic acid and chondroitin sulfate. (A) Purified
hyaluronic acid (15 mg) was incubated with whole venom or recombinant hyaluronidase at a ratio of 1:1 for 3 h at 37uC. Degradation was assayed
after agarose gel electrophoresis of the incubation mixture, followed by cetavlon precipitation and toluidine blue staining of the glycosaminoglycan
sample. Chondroitin sulfate (CS), dermatan sulfate (DS) and heparan sulfate (HS) were used as molecular mass markers. Lane 1 represents the
negative control (15 mg of purified hyaluronic acid), and lanes 2 and 3 show hyaluronic acid incubated with the venom and recombinant
hyaluronidase, respectively. (B) Purified chondroitin sulfate (CS) was incubated with venom (lane 2) or Dietrich’s Hyaluronidase (lane 3) at ratios of 1:1
for 16 h at 37uC. Chondroitin sulfate standard is shown in lane 1. (C) 5 mg of recombinant enzyme was submitted to zymography SDS-PAGE 10%
impregnated with 0.17 mg/mL hyaluronic acid (HA) or 0.34 mg/mL chondroitin sulfate (CS). The zymogram was developed overnight at 37uC under
pH 7.4 and the gel was stained with Alcian Blue and co-stained with Coomassie Blue. Black arrow indicates activity of recombinant hyaluronidase in
zymograms. Arrowhead shows persistent BSA residue after proteolysis performed before coloration. Molecular mass marker positions are shown in
the left of figure.
doi:10.1371/journal.pntd.0002206.g005
Figure 6. Macroscopic changes in rabbit skin exposed to whole venom, recombinant dermonecrotic toxin and Dietrich’s
Hyaluronidase. (A) Macroscopic visualization of skin injuries of rabbits intradermally injected with 10 mg of whole venom (as positive control),
10 mg of a recombinant protein not related to hyaluronic acid hydrolysis or dermonecrosis (IBs control) and PBS/BSA (negative controls). Lesions were
observed 0 and 24 h following injection. (B) Macroscopic visualization of skin injuries of rabbits intradermally injected with 10 mg of dermonecrotic
toxin (LiRecDT1), 10 mg of Dietrich’s Hyaluronidase (Dietrich’s Hyase), or both enzymes together (20 mg). Lesions were observed 0, 3, 6 and 24 h
following injections. Arrows point to spreading of erythema (3 and 6 h), ecchymosis (6 and 24 h) and gravitational spreading of necrotic lesions (24 h)
after injection of dermonecrotic toxin and Dietrich’s Hyaluronidase, compared to lesions developed only due to dermonecrotic toxin. (C) In detail,
comparison of dermonecrotic injuries developed due to venom or a mixture of recombinant hyaluronidase and phospholipase-D. Injections were
applied in the center of the triangle indicated by three dots. Scale bar is shown at right of each picture and represents 1 cm.
doi:10.1371/journal.pntd.0002206.g006
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the systemic circulation [1,2]. Literature data have reported signs
of systemic intoxication including fever, vomiting, hemolytic
anemia, thrombocytopenia, disseminated intravascular coagula-
tion, and nephrotoxicity following brown spider bites [1,2,4,31].
Moreover, brown spider venom hyaluronidase is also suggested
to play a role in the cutaneous lesions following bites, as described
for other venom hyaluronidases [23]. By disturbing the extracel-
lular matrix structure, venom hyaluronidase may influence the
Figure 7. Histopathological changes in rabbit skin exposed to recombinant dermonecrotic toxin and Dietrich’s Hyaluronidase. Light
microscopic analysis of tissue sections was performed on rabbit skin after 24 h of recombinant enzymes injection. The tissue sections were stained
with Massons’s trichrome. The scale bar at the bottom of the figures indicates 1 mm (A) or 100 mm (B). (A) Edema triggered in rabbit skin by the
combination of dermonecrotic toxin (LiRecDT1) and Dietrich’s Hyaluronidase (Dietrich’s Hyase), visualized by size. Comparison of the skin structures
via scanning of images from epidermal (on the left of figure) to muscular tissues (on the right of figure) under the same laboratory conditions
(magnification 156). (B) Skin exposed to recombinant dermonecrotic toxin, recombinant hyaluronidase, or recombinant hyaluronidase plus
recombinant dermonecrotic toxin changed the extracellular matrix in connective tissue: disorganization of collagen fibers (Fig. 7B-3, 7B-4, 7B-5 and
7B-6) (white arrows); fibrinoid exudate into the dermis (Fig. 7B-3, 7B-5 and 7B-6) (arrowheads); and intense inflammatory response with neutrophils
inside blood vessels and diffusely into the dermis structures (Fig. 7B-2, 7B-3, 7B-5 and 7B-6) (black arrows) are shown (magnification 4006).
doi:10.1371/journal.pntd.0002206.g007
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stability of blood vessel walls. These events may increase the
spread of other venom toxins, which in turn can cause the
cutaneous lesions that may follow after brown spider bites.
Corroborating previous ideas, our work shows that Dietrich’s
Hyaluronidase is able to degrade hyaluronic acid and chondroitin
sulfate in vitro and has increased the erythema and ecchymosis
cause by phospholipase-D injected into rabbit skin. We suggest
that this enzyme likely degrades both glycosaminoglycans in vivo. It
is known that low molecular weight HA fragments are pro-
inflammatory, immunostimulatory and angiogenic. Besides, HA
oligosaccharides formed due to plasma HA degradation may result
in hemostatic disturbances. Hence, exploring the in vivo fragmen-
tation of HA and the effects on pathophysiology of envenomation
might be a topic for further researches [59].
Another important feature that has been described for
hyaluronidases of venoms, such as from scorpions, bees, hornets
and wasps, is their classification as major allergens that can induce
anaphylaxis and sometimes death [21,60]. Based on its sequence
identity with other venom hyaluronidases, it is possible that the
brown spider venom hyaluronidase may act as a potential allergen
in susceptible individuals. This notion is strengthened by evidence
observed in the course of loxoscelism, which includes itch,
morbilliform erythema, cutaneous rash and petechial eruption
[1,2,31,61,62]. It might also suggest the involvement of the
immune system [63,64]. Cutaneous rashes respond to treatment
with systemic steroids [31,63]. Thus, the hyaluronidase from
Loxosceles genus could be further investigated as a molecule capable
of inducing allergy reactions. In the same way, whether allergy’s
molecular mechanism is due to the enzyme molecule itself or even
the HA fragments resulting from its glycosidase activity.
Besides a novel understanding of the pathogenesis of loxosce-
lism, Dietrich’s Hyaluronidase could be an important tool for
future biotechnological purposes [14,16]. Hyaluronidases are
known to be involved in physiological and pathological processes
such as bacterial pathogenesis, spread of toxins and venoms,
fertilization, and cancer progression [65,66,67,68].
For example, hyaluronidase recombinant molecules may be
developed as tools for in vitro fertilization [10]. On the other hand,
hyaluronidase inhibitors may serve as contraceptives, because they
are involved in the fertilization of eggs by mammalian sperm and
could thus be used to block fertilization. Other possible
applications of hyaluronidase inhibitors are as anti-tumor
[58,66], anti-bacterial [67] and anti-venom/toxin agents [16,20].
Interestingly, a cloned Buthus martensi hyaluronidase (BmHYA1)
down-regulated CD44 (a hyaluronic acid-ligand transmembrane
glycoprotein involved in cell–matrix connections) in a cancer cell
line, suggesting that a variant of cancer cells can be modulated by
external venom hyaluronidase treatment [24].
In summary, for the first time in the literature, we have
described a recombinant hyaluronidase from the venom glands of
Loxosceles sp. We cloned, expressed, purified and refolded this
enzyme, which showed degradative activity on hyaluronic acid
and chondroitin sulfate. This recombinant glycosidase increased
the area of dermonecrosis, gravitational spreading and edema
induced by a recombinant dermonecrotic toxin, mimicking the
profile of whole venom in an animal model for skin loxoscelism in
vivo. Finally, results showed the role of this enzyme as a spreading
factor in the mechanism of spreading of necrotic lesions followed
by brown spider envenomation. Together, these results provide
insights into loxoscelism and contribute to a further understanding
of venom mechanisms and will perhaps unveil novel treatment
protocols for envenomation or biotechnological applications for
this venom protein.
We propose naming this novel brown spider hyaluronidase
described herein as Dietrich’s Hyaluronidase, in memoriam and
honor of Professor Carl Peter Von Dietrich. Professor Dietrich was
born in 1936 in Rio de Janeiro, Brazil, graduated in medicine
from the Universidade do Estado do Rio de Janeiro, 1963, Rio de
Janeiro, Brazil, specialized in biochemistry at the Instituto de
Investigaciones Bioquimicas, 1963, Buenos Aires, Argentine, and
earned his doctorate at the University of Saskatchewan, 1970,
Saskatchewan, Canada. He was a professor and researcher in
biochemistry and molecular biology at the Universidade Federal
de Sa˜o Paulo, Sa˜o Paulo, Brazil, where he worked with
macromolecules such as proteoglycans, glycosaminoglycans and
heparins. Professor Dietrich died in 2005 in Sa˜o Paulo, Brazil.
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